Publications

Heard JR, Mitra AP. Noninvasive tests for bladder cancer detection and surveillance: a systematic review of commercially available assays. Bladder Cancer 10(1):71-81, 2024. [PubMed]

Castaneda PR, Luthringer D, Mitra AP. Hemorrhagic infarct secondary to vasculitis presenting as testicular mass. Urology 178:e197-e198, 2023. [PubMed]

Ghoreifi A, Mitra AP, McClintock G, Baky F, McDowell Z, Lavallée E, Saoud R, Cai J, Gill IS, Sfakianos J, Porter J, Bagrodia A, Ahmadi N, Eggener S, Ward JF, Djaladat H. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: a multicenter collaborative study. Urol Oncol 41(2):111.e7-111.e14, 2023. [PubMed]

Mokkapati S, Narayan VM, Manyam GC, Lim AH, Duplisea JJ, Kokorovic A, Miest TS, Mitra AP, Plote D, Anand SS, Metcalfe MJ, Dunner K Jr, Johnson BA, Czerniak BA, Nieminen T, Heikura T, Yla-Herttuala S, Parker NR, Schluns KS, McConkey DJ, Dinney CP. Lentiviral interferon: a novel method for gene therapy in bladder cancer. Mol Ther Oncolytics 26:141-157, 2022. [PubMed]

Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Antiadenovirus antibodies predict response durability to nadofaragene firadenovec therapy in BCG-unresponsive non–muscle-invasive bladder cancer: secondary analysis of a phase 3 clinical trial. Eur Urol 81(3):223-228, 2022. [PubMed] (Cover feature)

Mitra AP, Cai J, Miranda G, Bhanvadia S, Quinn DI, Schuckman AK, Djaladat H, Daneshmand S. Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the University of Southern California experience over 3,347 cases. J Urol 207(2):302-313, 2022. [PubMed] (Cover feature) (Editorial feature and Editorial comment)

Ghodoussipour S, Ghoreifi A, Katebian B, Cameron BH, Mitra AP, Cai J, Miranda G, Schuckman AK, Daneshmand S, Djaladat H. Enhanced recovery after cystectomy in patients with preoperative narcotic use. Can Urol Assoc J 15(11):E563-E568, 2021. [PubMed]

Yip W, Graham JN, Mitra AP, Chen AB, Aron M. Robotic-assisted laparoscopic partial nephrectomy in a renal transplant. Urol Video J 10:100082, 2021. [Fulltext]

Soria F, Sanchez-Carbayo M, Benderska-Söder N, Schmidz-Dräger BJ, Zamboni S, Moschini M, Mitra AP, Lotan Y. Bladder cancer tissue-based biomarkers. Soc Int Urol J 2(1):53-71, 2021. [Issue]

Ghodoussipour S, Naser-Tavakolian A, Cameron B, Mitra AP, Miranda G, Cai J, Bhanvadia S, Aron M, Desai M, Gill I, Schuckman A, Daneshmand S, Djaladat H. Internal audit of an enhanced recovery after surgery protocol for radical cystectomy. World J Urol 38(12):3131-3137, 2020. [PubMed]

Birkhäuser FD, Moltzahn F, Huber PM, Zehnder J, Flückiger S, Hasler D, Mitra AP, Zehnder P. Intensified and standardized digital communication with cystectomy patients as a potentially simple and effective modality for early detection of postoperative complications: results from a pilot study. Eur Urol Open Sci 22:3-8, 2020. [PubMed]

Mitra AP, Vasquez E, Kokorowski P, Chang AY. Robotic adrenalectomy in the pediatric population: initial experience case series from a tertiary center. BMC Urol 20(1):155, 2020. [PubMed]

Mitra AP, Chopra S, Ghodoussipour S, Schuckman AK. Heterotopic bone formation in clear cell renal cell carcinoma. Urology 144:13-14, 2020. [PubMed]

Ghoreifi A, Mitra AP, Cai J, Miranda G, Daneshmand S, Djaladat H. Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: a long-term, single-center study. Can Urol Assoc J 14(10):E493-E498, 2020. [PubMed]

Mitra AP, Maas M, Zainfeld DE, Schuckman AK. Pelvic hemangiopericytoma: a case report and review of the literature. Urol Case Rep 32:101247, 2020. [PubMed]

Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Hulsbergen-van de Kaa CA, Bruins HM, Daneshmand S. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Urol Oncol 37(1):48-56, 2019. [PubMed]

Soria F, Krabbe LM, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, Gust KM, Lotan Y, Shariat SF. Molecular markers in bladder cancer. World J Urol 37(1):31-40, 2019. [PubMed]

Mitra AP, Daneshmand S. Molecular prognostication in bladder cancer. Cancer Treat Res 175:165-191, 2018. [PubMed]

Seiler R, Lam LL, Erho N, Takhar M, Mitra AP, Buerki C, Davicioni E, Skinner EC, Daneshmand S, Black PC. Prediction of lymph node metastasis in patients with bladder cancer using whole transcriptome gene expression signatures. J Urol 196(4):1036-1041, 2016. (Cover feature) [PubMed]

Mitra AP. Molecular substratification of bladder cancer: moving towards individualized patient management. Ther Adv Urol 8(3):215-233, 2016. [PubMed]

Zehnder P, Moltzahn F, Mitra AP, Cai J, Miranda G, Skinner EC, Gill IS, Daneshmand S. Radical cystectomy with super-extended lymphadenectomy: impact of separate versus en bloc lymph node submission on analysis and outcomes. BJU Int 117(2):253-259, 2016. [PubMed]

Bartsch G Jr, Mitra AP, Mitra SA, Almal AA, Steven KE, Skinner DG, Fry DW, Lenehan PF, Worzel WP, Cote RJ. Use of artificial intelligence and machine learning algorithms with gene expression profiling to predict recurrent nonmuscle invasive urothelial carcinoma of the bladder. J Urol 195(2):493-498, 2016. [PubMed]

Mitra AP, Lerner SP. Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the Cancer Genome Atlas and beyond. Urol Clin North Am 42(2):201-215, 2015. [PubMed]

Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology 84(6):1420-1426, 2014. [PubMed]

Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of novel expression signature for post-cystectomy recurrence in high-risk bladder cancer. J Natl Cancer Inst 106(11):dju290, 2014. (Editorial comment) (2016 EAU Prize for Best Paper published in Urological Literature on Clinical Research) [PubMed]

Daneshmand S, Ahmadi H, Schuckman AK, Mitra AP, Cai J, Miranda G, Djaladat H. Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol 192(1):50-56, 2014. (Cover feature) (Editorial feature and Editorial comment) [PubMed]

Jayaratna IS, Mitra AP, Schwartz RL, Dorff TB, Schuckman AK. Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the western United States. Clin Genitourin Cancer 12(2):138-142, 2014. [PubMed]

Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer Prostatic Dis 17(1):64-69, 2014. [PubMed]

Mitra AP, Bartsch CC, Bartsch G Jr, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol 32(2):117-127, 2014. [PubMed]

Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients. Urol Oncol 32(1):52.e1-52.e9, 2014. [PubMed]

Zehnder P, Moltzahn F, Daneshmand S, Leahy M, Cai J, Miranda G, Bartsch G Jr, Mitra AP, Skinner DG, Skinner EC, Gill IS. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU Int 113(1):65-69, 2014. [PubMed]

Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes. Int J Urol 20(12):1229-1233, 2013. [PubMed]

Karnes RJ, Bergstralh EJ, Davicioni E, Ghadessi M, Buerki C, Mitra AP, Crisan A, Erho N, Vergara IA, Lam LL, Carlson R, Thompson DJS, Haddad Z, Zimmermann B, Sierocinski T, Triche TJ, Kollmeyer T, Ballman KV, Black PC, Klee GG, Jenkins RB. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol 190(6):2047-2053, 2013. [PubMed]

Birkhahn M, Mitra AP, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. Eur J Cancer 49(15):3159-3168, 2013. (Editorial feature) [PubMed]

Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhäuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int 112(2):E51-E58, 2013. [PubMed]

Erho N, Crisan A, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche TJ, Black PC, Karnes RJ, Klee G, Davicioni E, Jenkins RB. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One 8(6):e66855, 2013. (Top 1% most cited PLoS One article) [PubMed]

Badani K, Thompson DJ, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra AP, Wood PJ, Hornberger J. Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group. Oncotarget 4(4):600-609, 2013. [PubMed]

Ahmadi H, Mitra AP, Abdelsayed GA, Cai J, Djaladat H, Bruins HM, Daneshmand S. Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer. BJU Int 111(4b):E167-E172, 2013. [PubMed]

Bruins HM, Wopat R, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU Int 111(3b):E37-E42, 2013. [PubMed]

Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program. Cancer 119(4):756-765, 2013. (Cancer/ACS feature press release) (Editorial comment) [PubMed]

Mitra AP, Skinner EC, Miranda G, Daneshmand S. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU Int 111(2):240-248, 2013. (Editorial feature) [PubMed]

Mitra AP, Hansel DE, Cote RJ. Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39(5):524-533, 2012. [PubMed]

Mitra AP, Jordà M, Cote RJ. Pathological possibilities and pitfalls in detecting aggressive bladder cancer. Curr Opin Urol 22(5):397-404, 2012. [PubMed]

Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int 109(6):846-854, 2012. [PubMed]

Mitra SA, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. Front Genet 3:17, 2012. [PubMed]

Mitra AP, Cote RJ. Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales? Expert Rev Anticancer Ther 11(6):849-852, 2011. (Cover feature) [PubMed]

Kapur P, Lotan Y, King E, Kabbani W, Mitra AP,  Mosbah A, Abol-Enein H, Ghoniem M, Youssef RF. Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers. Am J Clin Pathol 135(6):822-830, 2011. [PubMed]

Bartsch G, Mitra AP, Cote RJ. Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10(12):1945-1954, 2010. (Cover feature) [PubMed]

Mitra AP, Cote RJ. Molecular screening for bladder cancer: progress and potential. Nature Rev Urol 7(1):11-20, 2010. [PubMed]

Birkhahn M, Mitra AP, Williams AJ, Lam G, Ye W, Datar RH, Balic M, Groshen S, Steven KE, Cote RJ. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur Urol 57(1):12-20, 2010. (Platinum priority) [PubMed]

Mitra AP, Bartsch CC, Cote RJ. Strategies for molecular expression profiling in bladder cancer. Cancer Metastasis Rev 28(3-4):317-326, 2009. [PubMed]

Mitra AP, Pagliarulo V, Yang D, Waldman FM, Datar RH, Skinner DG, Groshen S, Cote RJ. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 27(24):3929-3937, 2009. [PubMed]

Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol 4:251-285, 2009. [PubMed]

Youssef RF, Mitra AP, Bartsch G Jr, Jones PA, Skinner DG, Cote RJ. Molecular targets and targeted therapies in bladder cancer management. World J Urol 27(1):9-20, 2009. [PubMed]

Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 10(1):31-43, 2008. (Cover feature) [PubMed]

Birkhahn M, Mitra AP, Cote RJ. Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev Anticancer Ther 7(12):1717-1727, 2007. (Cover feature) [PubMed]

Mitra AP, Birkhahn M, Cote RJ. p53 and retinoblastoma pathways in bladder cancer. World J Urol 25(6):563-571, 2007. [PubMed]

Mitra AP, Cote RJ. Searching for novel therapeutics and targets: insights from clinical trials. Urol Oncol 25(4):341-343, 2007. [PubMed]

Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24(35):5552-5564, 2006. (Cover feature) [PubMed]

Mitra AP, Lin H, Datar RH, Cote RJ. Molecular biology of bladder cancer: prognostic and clinical implications. Clin Genitourin Cancer 5(1):67-77, 2006. (Cover feature) [PubMed]

Mitra AP, Almal AA, George B, Fry DW, Lenehan PF, Pagliarulo V, Cote RJ, Datar RH, Worzel WP. The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer 6:159, 2006. (Highly accessed) [PubMed]

Mitra AP, Lin H, Cote RJ, Datar RH. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management. Natl Med J India 18(6):304-312, 2005. [PubMed]

Mitra AP, Datar RH, Cote RJ. Molecular staging of bladder cancer. BJU Int 96(1):7-12, 2005. [PubMed]

Cote RJ, Mitra AP. Molecular biology of bladder cancer. In: Canellos GP, Schnipper L (editors). UpToDate. Waltham, MA: Wolters Kluwer Health; 2020 (with recurring updates). www.UpToDate.com

Mitra AP, Birkhahn M, Penson DF, Cote RJ. Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder. In: Canellos GP, Schnipper L (editors). UpToDate. Waltham, MA: Wolters Kluwer Health; 2009 (with recurring updates). www.UpToDate.com

Soria F, Benderska-Söder N, Mitra AP, Moschini M, Sánchez-Carbayo M, Schmitz-Dräger BJ, Zamboni S. Bladder cancer tissue-based biomarkers. In: Lotan Y, Lawrentschuk N, Schalken J (editors). 1st ICUD-WUOF International Consultation on Molecular Biomarkers in Urologic Oncology. Toronto, Canada: World Urologic Oncology Federation; 2020. p. 266-306.

Shariat SF, Lotan Y, Dobruch J, Gust KM, Inman BA, Krabbe LM, Mitra AP, Soria F, Todenhöfer T. Molecular Markers. In: Black P, Gontero P (editors). Bladder Cancer: A Joint SIU-ICUD International Consultation. Montréal, Canada: Société Internationale d’Urologie; 2018. p. 285-371.

Mitra AP, Daneshmand S. Molecular prognostication in bladder cancer. In: Daneshmand S, Chan KG (editors). Genitourinary Cancers. Cham, Switzerland: Springer Nature; 2018. p. 165-191.

Mitra AP, Bartsch G Jr, Cote RJ. Risk factors and molecular features associated with bladder cancer development. In: Hansel DE, Lerner SP (editors). Precision Molecular Pathology of Bladder Cancer. Cham, Switzerland: Springer Nature; 2018. p. 3-28.

Xylinas E, Mitra AP, Daneshmand S, Shariat SF. Molecular markers for screening, detection and prognosis of bladder cancer. In: Xylinas E, Shariat SF (editors). Advances in Bladder Cancer Management. London, UK: Future Medicine; 2015. p. 62-88.

Mitra AP. Bladder cancer. In: Colditz GA (editor). The SAGE Encyclopedia of Cancer and Society, 2nd ed. Thousand Oaks, CA: Sage Publications; 2015. p. 148-149.

Mitra AP. Bladder cancer, childhood. In: Colditz GA (editor). The SAGE Encyclopedia of Cancer and Society, 2nd ed. Thousand Oaks, CA: Sage Publications; 2015. p. 149-151.

Mitra AP. Chemotherapy. In: Colditz GA (editor). The SAGE Encyclopedia of Cancer and Society, 2nd ed. Thousand Oaks, CA: Sage Publications; 2015. p. 270-276.

Mitra AP. Assisted suicide. In: Colditz GA (editor). The SAGE Encyclopedia of Cancer and Society, 2nd ed. Thousand Oaks, CA: Sage Publications; 2015. p. 97-100.

Mitra AP. Developing countries. In: Colditz GA (editor). The SAGE Encyclopedia of Cancer and Society, 2nd ed. Thousand Oaks, CA: Sage Publications; 2015. p. 349-351.

Mitra AP. Daily life. In: Colditz GA (editor). The SAGE Encyclopedia of Cancer and Society, 2nd ed. Thousand Oaks, CA: Sage Publications; 2015. p. 334-336.

Shin H, Vergara IA, Mitra AP, Triche TJ, Davicioni E. Novel molecular and genotype profiling in prostate cancer: the future of screening, diagnosis, and staging. In: Dicker AP, Kelly WK, Zaorsky NG, Trabulsi EJ (editors). Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management. New York, NY: Demos Medical; 2015. p. 77-83.

Mitra SA, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. In: Kapranov P (editor). Genomic "Dark Matter": Implications for Understanding Human Disease Mechanisms, Diagnostics, and Cures. Lausanne, Switzerland: Frontiers Media SA; 2012. p. 70-78.

Mitra AP, Theodorescu D, Lerner SP, Cote RJ, Datar RH. Molecular biology and prognostic markers in bladder cancer. In: Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, Sheinfeld J, Rini BI, Bochner BH (editors). Comprehensive Textbook of Genitourinary Oncology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 317-333.

Cote RJ, Mitra AP, Amin MB. Bladder and urethra. In: Weidner N, Cote RJ, Suster S, Weiss LM (editors). Modern Surgical Pathology, 2nd ed. Philadelphia, PA: Saunders; 2009. p. 1079-1120.

Mitra AP. Assisted suicide. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 65-67.

Mitra AP. Bladder cancer, childhood. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 109-110.

Mitra AP. Chemotherapy. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 187-195.

Mitra AP. Daily life. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 250-252.

Mitra AP. Developing countries. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 265-267.

Mitra AP. Roche group (Switzerland). In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 747-748.

Mitra AP. Technology, imaging. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications; 2007. p. 882-884.

Ghoreifi A, Moghaddam FS, Mitra AP, Khanna A, Virk A, Baky F, Mcdowell Z, Ho M, Roberts J, Gill I, Eggener S, Porter J, Ahmadi N, Mehrazin R, Sfakianos J, Bagrodia A, Hamilton R, Rawal S, Ward JF, Djaladat H. Predictors and outcomes of open conversion during robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Western Section AUA Annual Meeting: 2023 Oct 1-5; Lake Tahoe, CA. (Moderated Poster)

Ghoreifi A, Mitra A, Khanna A, Rich J, McClintock G, Baky F, Mcdowell Z, Ho M, Roberts J, Moghaddam FS, Haque T, Gill I, Eggener S, Porter J, Ahmadi N, Mehrazin R, Sfakianos J, Bagrodia A, Rawal S, Ward J, Djaladat H. Oncological outcomes following robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: a worldwide multicenter study. AUA Annual Meeting: 2023 Apr 28-May 1; Chicago, IL. (Moderated Poster)

Mitra AP. Recent advances in management of non-muscle-invasive bladder cancer. What's New in Urology: A Primer for the Primary Care Provider: 2023 Apr 22; Los Angeles, CA. (Presentation)

Mitra, AP,Mokkapati S, Navai N, Kamat AM, McConkey DJ, Dinney CPN. Generation and validation of a predictive urine-microRNA signature for intravesical BCG therapy. SUO Annual Meeting: 2022 Nov 30-Dec 2; San Diego, CA. (Poster)

Ghoreifi A, Lavallée E, Mitra AP, McClintock G, Baky F, McDowell Z, Saoud R, Cai J, Gill IS, Porter J, Bagrodia A, Ahmadi N, Eggener S, Ward JF, Sfakianos J, Djaladat H. Outcomes of obese patients undergoing robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Western Section AUA Annual Meeting: 2022 Oct 30-Nov 4; Koloa, HI. (Unmoderated Poster)

Mitra AP, Mokkapati S, Grossman HB, Kamat AM, McConkey DJ, Dinney CPN. Urine microRNAs as liquid biopsy assay for predicting response to intravesical BCG therapy. AUA Annual Meeting: 2022 May 13-16; New Orleans, LA. (Moderated Poster) (Best Poster Award)

Mitra AP, Mokkapati S, Miest TS, Narayan VM, Philipson R, Yla-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Evaluating intravesical nadofaragene firadenovec and immune checkpoint blockade combination therapy in BCG-unresponsive non-muscle-invasive bladder cancer: evidence from a phase 3 trial. AUA Annual Meeting: 2022 May 13-16; New Orleans, LA. (Moderated Poster)

Miest T, Rudzinski J, Mokkapati S, Sood A, Mitra A, Dinney C. Patient-derived bladder tumor organoids for individualized preclinical characterization of nadofaragene firadenovec interferon gene therapy. AUA Annual Meeting: 2022 May 13-16; New Orleans, LA. (Presentation)

Mokkapati S, Rudzinski J, Miest T, Mitra A, Sood A, McConkey D, Dinney C. Interferon α gene therapy alters tumor metabolism in bladder cancer. AUA Annual Meeting: 2022 May 13-16; New Orleans, LA. (Presentation)

Mitra AP, Cai J, Miranda G, Bhanvadia S, Quinn DI, Schuckman AK, Djaladat H, Daneshmand S. Management and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the University of Southern California experience over 3,347 cases. SUO Annual Meeting: 2021 Dec 1-3; Orlando, FL. (Poster)

Mitra AP, Mitra SA, Buckley JD, Skapek SX, Hawkins DS, Triche TJ. Coding and non-coding gene meta-features predict outcome in pediatric rhabdomyosarcomas. AACR Annual Meeting: 2022 Apr 8-13; New Orleans, LA. (Poster)

Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni Jr J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole Jr GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Anti-adenoviral antibody levels predict nadofaragene firadenovec response durability in BCG-unresponsive non-muscle-invasive bladder cancer: results from a phase 3 clinical trial. SUO Annual Meeting: 2021 Dec 1-3; Orlando, FL. (Poster) (Best of SUO)

Mitra AP, Mokkapati S, Kokorovic A, Grossman HB, Kamat AM, McConkey DJ, Dinney CPN. Predicting response to intravesical BCG therapy using urine microRNAs as a liquid biopsy assay. SUO Annual Meeting: 2021 Dec 1-3; Orlando, FL. (Poster) (Best YUO Poster)

Mitra AP, Mokkapati S, Miest TS, Narayan VM, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Rationale for intravesical IFNA2 replacement and immune checkpoint blockade combination therapy in BCG-unresponsive non-muscle-invasive bladder cancer: evidence from the nadofaragene firadenovec phase 3 trial. SUO Annual Meeting: 2021 Dec 1-3; Orlando, FL. (Poster) (Best of SUO)

Ghoreifi A, Mitra, AP, McClintock G, Baky F, McDowell Z, Lavallée E, Gill IS, Eggener S, Sfakianos JP, Porter J, Bagrodia A, Ahmadi N, Ward JF, Djaladat H. Robotic post-chemotherapy retroperitoneal lymph node dissection for germ cell tumor: a multicenter study. SUO Annual Meeting: 2021 Dec 1-3; Orlando, FL. (Poster)

Miest T, Mokkapati S, Mitra A, Mountain J, Rudzinski J, McConkey DJ, Dinney CPN. Patient-derived bladder tumor organoids for individualized preclinical characterization of nadofaragene firadenovec interferon gene therapy. SUO Annual Meeting: 2021 Dec 1-3; Orlando, FL. (Poster)

Mitra AP, Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni Jr J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole Jr GL, Sankin AI, Boyd A, O'Donnell MA, Yang M, Sawutz D, Philipson R, Ylä-Herttuala S, Parker NR, Dinney CPN. Anti-adenoviral antibody levels predict nadofaragene firadenovec response in BCG-unresponsive NMIBC: results from a phase 3 trial. AUA Annual Meeting: 2021 Sep 10-13; Las Vegas, NV. (Presentation)

Mitra AP, Kokorovic A, Miest TS, Narayan VM, Sundi D, Lim A, Mokkapati S, Dinney CPN. FOXF1 is a novel regulator of nodal metastasis in bladder cancer. AUA Annual Meeting: 2021 Sep 10-13; Las Vegas, NV. (Presentation)

Mitra AP, Cai J, Miranda G, Bhanvadia S, Aron M, Desai MM, Quinn DI, Schuckman AK, Djaladat H, Gill IS, Daneshmand S. Evolving trends in surgical and oncologic outcomes following radical cystectomy: long-term experience at the University of Southern California. AUA Annual Meeting: 2021 Sep 10-13; Las Vegas, NV. (Presentation)

Ghoreifi A, Mitra AP, Baky F, McDowell Z, Gill I, Eggener S, Porter J, Bagrodia A, Ward JF, Djaladat H. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: a multicenter collaborative study. AUA Annual Meeting: 2021 Sep 10-13; Las Vegas, NV. (Presentation) (AUA Take Home Message - Robotic Surgery)

Mitra AP, Kokorovic A, Miest T, Narayan VM, Sundi D, Lim A, Mokkapati S, Dinney CPN. Characterization of FOXF1 as a novel regulator of nodal metastasis in bladder cancer. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2021 Feb 11-13; virtual. (Poster) (Featured in Poster Highlights Session)

Miest T, Mitra AP, Narayan VM, Dinney CPN, Mokkapati S. Bladder tumor metabolic alterations in response to IFNα gene therapy. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2021 Feb 11-13; virtual. (Poster)

Mitra AP, Maas M, Mitra SA. A metagenomic approach to identifying novel therapeutic targets in bladder cancer. SUO Annual Meeting: 2020 Dec 3-5; virtual. (Poster)

Mitra AP, Kokorovic A, Miest TS, Narayan V, Sundi D, Lim A, Mokkapati S, Dinney CPN. Identification and biologic characterization of FOXF1 as a novel regulator of bladder cancer metastasis. SUO Annual Meeting: 2020 Dec 3-5; virtual. (Poster)

Miest TS, Mitra AP, Narayan V, Dinney CPN, Mokkapati S. Bladder tumor metabolic alterations in response to IFNa gene therapy predict clinical disease response and identify clinically targetable tumor escape pathways. SUO Annual Meeting: 2020 Dec 3-5; virtual. (Poster)

Fisch R, Ghodoussipour SB, Jiang D, Mitra AP, Ladi-Seyedian S, Miranda G, Schuckman AK, Djaladat H, Bhanvadia SK, Daneshmand S. Contemporary outcomes of primary urethral cancer at a tertiary care center. Western Section AUA Annual Meeting: 2020 Oct 24-29; virtual. (Poster)

Ghoreifi A, Chopra S, Asanad K, Mass M, Mitra A, Thompson E, Shah A, Gonzalez G, Nabhani J, Djaladat H. The effect of vesicopexy on urinary continence recovery following robotic-assisted radical prostatectomy: feasibility and early outcomes. Western Section AUA Annual Meeting: 2020 Oct 24-29; virtual. (Poster)

Ghoreifi A, Chopra S, Asanad K, Mass M, Mitra A, Thompson E, Shah A, Gonzalez G, Nabhani J, Djaladat H. The effect of vesicopexy on urinary continence recovery following robotic-assisted radical prostatectomy: feasibility and technique. Western Section AUA Annual Meeting: 2020 Oct 24-29; virtual. (Video Presentation)

Mitra AP. Identifying novel therapeutic targets based on perturbation of bladder cancer cellular circuitry using metagenomics. AUA Annual Meeting: 2020 May 15-18; virtual. (Moderated Poster)

Mitra AP, Graham JN, Aron M. Partial nephrectomy in a transplanted kidney using a robotic-assisted approach. AUA Annual Meeting: 2020 May 15-18; virtual. (Moderated Video)

Ghodoussipour S, Basin MF, Ahmadi H, Seyedian SL, Nusbaum DJ, Mitra A, Piatti P, Suwoto M, Yamada T, Gray M, Jara B, Chew YC, Bhanvadia S, Djaladat H, Schuckman A, Daneshmand S, Liang G. A urine-based DNA methylation test to monitor response to neoadjuvant chemotherapy in bladder cancer. AUA Annual Meeting: 2020 May 15-18; virtual. (Moderated Poster)

Ghodoussipour S, Nusbaum D, Pearce S, Ahmadi H, Basin M, Seyedian SL, Ghoreifi A, Mitra A, Shah A, Nassiri N, Prem A, Ullmer W, Jara B, Piatti P, Chew YC, Bhanvadia S, Djaladat H, Schuckman A, Liang G, Daneshmand S. The urinary microbiome after radical cystectomy and urinary diversion. AUA Annual Meeting: 2020 May 15-18; virtual. (Moderated Poster)

Shakir A, Ghoreifi A, Mitra A, Djaladat H. Robotic partial nephrectomy in a solitary functional kidney with renal vein thrombosis. AUA Annual Meeting: 2020 May 15-18; virtual. (Moderated Video)

Yip W, Graham J, Mitra A, Titus M, Blasic V, Aron M, Kim M. Opioid sparing enhanced recovery after surgery pathway for robotic prostatectomy. Western Section AUA Annual Meeting: 2019 Nov 3-7; Monterey, CA. (Presentation)

Ghoreifi A, Mitra AP, Cai J, Miranda G, Daneshmand S, Djaladat H. Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: a long-term single-center study. Western Section AUA Annual Meeting: 2019 Nov 3-7; Monterey, CA. (Unmoderated Poster)

Jiang D, Ghodoussipour SB, Mitra AP, Daneshmand S. Contemporary outcomes of primary urethral cancer at a tertiary care center. Western Section AUA Annual Meeting: 2019 Nov 3-7; Monterey, CA. (Unmoderated Poster)

Mitra AP, Mitra SA, Daneshmand S. Employment of a metagenomic approach to identify putative prognostic biomarkers that perturb the cellular circuitry in bladder cancer. AUA Annual Meeting: 2019 May 3-6; Chicago, IL. (Moderated Poster)

Mitra AP, Nabhani J, Monga M, Nguyen M. Racial variations in attitudes of urolithiasis patients towards adopting stone prevention strategies. AUA Annual Meeting: 2019 May 3-6; Chicago, IL. (Moderated Poster)

Graham JN, Mitra A, Aron M. Robotic assisted laparoscopic partial nephrectomy in a renal transplant. Annual North American Robotic Urologic Symposium: 2019 Feb 8-9; Las Vegas, NV. (Video Presentation)

Graham JN, Shakir A, Mitra A, Aron M. Peritoneal flap creation after robotic pelvic lymph node dissection and the incidence of symptomatic lymphocele formation. Annual North American Robotic Urologic Symposium: 2019 Feb 8-9; Las Vegas, NV. (Presentation)

Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Bruins HM, Daneshmand S. A multi-institutional investigation of the influence of micropapillary urothelial carcinoma variant on prognosis after radical cystectomy. SUO Annual Meeting: 2018 Nov 28-30; Phoenix, AZ. (Poster)

Mitra AP, Mitra SA, Daneshmand S. Using metagenomics to identify prognostic biomarkers that influence cellular networks in bladder cancer. SUO Annual Meeting: 2018 Nov 28-30; Phoenix, AZ. (Poster)

Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Bruins HM, Daneshmand S. A multi-institutional analysis of the impact of micropapillary urothelial carcinoma on prognosis after radical cystectomy. Western Section AUA Annual Meeting: 2018 Oct 28-Nov 2; Maui, HI. (Moderated Poster) (Third Place, Best of Session Award)

Mitra AP, Nabhani J, Monga M, Nguyen M. Racial variations in urolithiasis patients' attitudes towards adopting stone prevention strategies. Western Section AUA Annual Meeting: 2018 Oct 28-Nov 2; Maui, HI. (Presentation)

Mitra AP, Djaladat H, Schuckman AK, Daneshmand S. Neoadjuvant chemotherapy in invasive bladder cancer: critical analysis from a large institutional cohort. Western Section AUA Annual Meeting: 2018 Oct 28-Nov 2; Maui, HI. (Unmoderated Poster)

Mitra SA, Mitra AP, Liu Y, Buckley JD, Triche TJ. The functional noncoding genome in childhood sarcomas plays important regulatory roles in tumor pathogenesis. AACR Annual Meeting: 2018 Apr 14-18; Chicago, IL. (Poster)

Pepper M, Pettersson J, Chong T, Mitra A, Campan M, Mehta A, Ward P, Dubeau L. Molecular progression of superficial papillary urothelial carcinoma of the renal pelvis to a metastatic lesion. AMP Annual Meeting: 2017 Nov 16-18; Salt Lake City, UT. (Poster)

Bazargani S, Ghodoussipour S, Shah A, Thompson E, Mitra A, Dunn M. Does a partial prostate resection improve voiding symptoms while shortening the learning curve for HOLEP? World Congress of Endourology: 2017 Sep 12-16; Vancouver, BC. (Moderated Poster)

Bazargani S, Ghodoussipour S, Thompson E, Shah A, Mitra A, Dunn M. Limitations of the Lithovue single use digital flexible ureteroscope. World Congress of Endourology: 2017 Sep 12-16; Vancouver, BC. (Moderated Poster)

Ghodoussipour S, Shah A, Thompson E, Mitra A, Dunn M. Does a partial prostate resection improve voiding symptoms while shortening the learning curve for HOLEP? AUA Annual Meeting: 2017 May 12-16; Boston, MA. (Moderated Poster)

Ghodoussipour S, Thompson E, Shah A, Mitra A, Deshmukh S, Dunn M. Limitations of the LithoVue single use digital flexible ureteroscope. AUA Annual Meeting: 2017 May 12-16; Boston, MA. (Moderated Poster)

Mitra SA, Mitra AP, Nagy JO, Buckley JD, Triche TJ. Metastasis promoting long non-coding RNA, FEZF1-AS1, is an important therapeutic target for Ewing sarcoma. AACR Annual Meeting: 2017 Apr 1-5; Washington, DC. (Poster)

Mitra AP. Identifying prognostic genomic signatures and key molecular pathologic drivers in high-risk bladder cancer. John P Stein Memorial Resident Research Symposium, Los Angeles Urological Society Meeting: 2016 Jun 8; Los Angeles, CA. (Presentation)

Mitra SA, Mitra AP, Buckley JD, Triche TJ. Ewing sarcoma associated long non-coding RNA determines neural cell fate of the tumors. AACR Annual Meeting: 2016 Apr 16-20; New Orleans, LA. (Poster)

Mitra AP, Djaladat H, Schuckman AK, Daneshmand S. Role of neoadjuvant chemotherapy in patients with cT4aN0 bladder cancer. Western Section AUA Annual Meeting: 2015 Oct 25-29; Indian Wells, CA. (Moderated Poster)

Mitra AP, Quinn DI, Skinner EC, Dorff TB, Schuckman AK, Daneshmand S. Outcomes following post-cystectomy recurrence of bladder cancer based on metastatic site. AUA Annual Meeting: 2015 May 15-19; New Orleans, LA. (Presentation)

Mitra AP, Skinner EC, Schuckman AK, Daneshmand S. Factors determining lymph node yield during radical cystectomy with pelvic lymphadenectomy before and after implementing node-packeting. AUA Annual Meeting: 2015 May 15-19; New Orleans, LA. (Presentation)

Seiler R, Lam L, Erho N, Davicioni E, Mitra AP, Skinner EC, Daneshmand S, Black PC. Can bladder cancer gene expression signatures be used to predict lymph node metastasis at the time of radical cystectomy? AUA Annual Meeting: 2015 May 15-19; New Orleans, LA. (Presentation)

Mitra AP, Mitra SA, Buckley JD, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Discovery and independent validation of prognostic protein-coding and non-coding genomic meta-features in rhabdomyosarcoma. AACR Annual Meeting: 2015 Apr 18-22; Philadelphia, PA. (Presentation)

Mitra SA, Mitra AP, Buckley JD, Triche TJ. Coding and non-coding gene targets in pediatric soft tissue sarcomas. AACR Annual Meeting: 2015 Apr 18-22; Philadelphia, PA. (Poster)

Mitra AP, Quinn DI, Skinner EC, Dorff TB, Schuckman AK, Daneshmand S. Bladder cancer post-recurrence outcomes following cystectomy based on site of metastasis. SUO Annual Meeting: 2014 Dec 3-5; Bethesda, MD. (Poster)

Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. A novel validated genomic signature provides superior prognostic performance in high-risk bladder cancer following cystectomy. Western Section AUA Annual Meeting: 2014 Oct 26-31; Maui, HI. (Presentation) (First Place, Joseph F. McCarthy Physician Essay Contest)

Mitra AP, Skinner EC, Schuckman AK, Daneshmand S. Factors influencing lymph node yield during radical cystectomy with extended pelvic lymphadenectomy: experience before and after implementing institutional node-packeting protocols. Western Section AUA Annual Meeting: 2014 Oct 26-31; Maui, HI. (Moderated Poster)

Mitra AP, Schuckman AK, Skinner EC, Lieskovsky G, Daneshmand S. Trends in urinary diversion following radical cystectomy: evolving experience of a single-institution over 25 years. Western Section AUA Annual Meeting: 2014 Oct 26-31; Maui, HI. (Unmoderated Poster)

Mitra AP, Quinn DI, Skinner EC, Dorff TB, Schuckman AK, Daneshmand S. Post-recurrence survival in bladder cancer following radical cystectomy based on metastatic site. Western Section AUA Annual Meeting: 2014 Oct 26-31; Maui, HI. (Unmoderated Poster)

Dalag L, Hu B, Tran K, Togawa K, Mitra AP, Duddalwar V, Daneshmand S. Anatomic locations of local recurrence sites after radical cystectomy and subsequent survival. Western Section AUA Annual Meeting: 2014 Oct 26-31; Maui, HI. (Moderated Poster)

Mitra AP. Discovery and validation of prognostic genomic-based signatures in high-risk bladder cancer following cystectomy. BCAN Bladder Cancer Think Tank: 2014 Aug 7-9; San Diego, CA. (Presentation) (John Quale Travel Fellowship Award)

Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. A combination of genomic markers and clinical variables provides superior prognostic performance in high-risk bladder cancer following cystectomy. AUA Annual Meeting: 2014 May 16-21; Orlando, FL. (Moderated Poster)

Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Impact of gender on post-cystectomy bladder cancer outcomes: Differences in observations between matched and unmatched case-control approaches. AUA Annual Meeting: 2014 May 16-21; Orlando, FL. (Moderated Poster)

Mitra AP, Schuckman AK, Skinner EC, Daneshmand S. Pelvic recurrence following radical cystectomy and its impact on bladder cancer outcomes. AUA Annual Meeting: 2014 May 16-21; Orlando, FL. (Moderated Poster) (AUA Take Home Messages - Bladder Cancer)

Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of a novel expression signature for predicting recurrence in high-risk bladder cancer post-cystectomy. EAU Annual Congress: 2014 Apr 11-15; Stockholm, Sweden. (Moderated Poster) (Best Poster Award)

Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Identification of novel prognostic signatures in rhabdomyosarcoma by whole transcriptome expression profiling: a discovery and validation study. AACR Annual Meeting: 2014 Apr 5-9; San Diego, CA. (Poster)

Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Long non-coding RNA promotes metastatic behavior in Ewing sarcoma. AACR Annual Meeting: 2014 Apr 5-9; San Diego, CA. (Poster)

Mitra AP, Haydel D, Mitra SA, Wang L, Triche TJ. Differential diagnosis of small round cell tumors by transcriptome-wide expression profiling. USCAP Annual Meeting: 2014 Mar 1-7; San Diego, CA. (Presentation)

Mitra A, Lam L, Erho N, Ghadessi M, Vergara I, Alshalalfa M, Triche T, Davicioni E, Black P, Daneshmand S. Combination of genomic markers and clinical variables provides superior prognostic performance in high-risk bladder cancer following radical cystectomy. SUO Annual Meeting: 2013 Dec 4-6; Bethesda, MD. (Presentation)

Mitra A, Skinner E, Schuckman A, Quinn D, Dorff T, Daneshmand S. A critical analysis of the influence of gender on bladder cancer outcomes following radical cystectomy. SUO Annual Meeting: 2013 Dec 4-6; Bethesda, MD. (Poster)

Mitra A, Alemozaffar M, Harris B, Schuckman A, Miranda G, Skinner E, Daneshmand S. Outcomes following urothelial recurrence in bladder cancer patients undergoing radical cystectomy. SUO Annual Meeting: 2013 Dec 4-6; Bethesda, MD. (Poster)

Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Outcomes following radical cystectomy for bladder cancer: A critical analysis of the influence of patient gender. Western Section AUA Annual Meeting: 2013 Nov 3-7; Monterey, CA. (Moderated Poster)

Mitra AP, Schuckman AK, Skinner EC, Daneshmand S. Pelvic recurrence following radical cystectomy for urothelial carcinoma of the bladder. Western Section AUA Annual Meeting: 2013 Nov 3-7; Monterey, CA. (Moderated Poster) (First Place, Best of Session Award)

Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Discovery and validation of novel prognostic genomic signatures in rhabdomyosarcoma. AACR Special Conference – Pediatric Cancer at the Crossroads: Translating Discovery Into Improved Outcomes: 2013 Nov 3-6; San Diego, CA. (Poster)

Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Therapeutic importance of a long non-coding RNA in Ewing sarcoma. AACR Special Conference – Pediatric Cancer at the Crossroads: Translating Discovery Into Improved Outcomes: 2013 Nov 3-6; San Diego, CA. (Poster)

Feng FY, Ghadessi M, Davicioni E, Crisan A, Erho N, Mitra AP, Triche TJ, Jenkins RB, Ross AE, Schaeffer EM. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. ASTRO Annual Meeting: 2013 Sep 22-25; Atlanta, GA. (Presentation)

Badani K, Thompson D, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra A, Wood P, Hornberger J. Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group. Congress of the Société Internationale d’Urologie: 2013 Sep 8-12; Vancouver, BC. (Moderated Poster) (Best Poster Award)

Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Genomic and epigenomic interactions of an Ewing sarcoma-specific long non-coding RNA. AACR Special Conference on Chromatin and Epigenetics in Cancer: 2013 Jun 19-22; Atlanta, GA. (Presentation)

Mitra AP, Erho N, Lam LLC, Vergara IA, Sierocinski T, Zimmermann B, Haddad Z, Ghadessi M, Crisan A, Triche TJ, Daneshmand S, Buerki C, Davicioni E, Black PC. Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer. ASCO Annual Meeting: 2013 May 31-Jun 4; Chicago, IL. (Poster)

Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Feng FY, Schaeffer EM. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. ASCO Annual Meeting: 2013 May 31-Jun 4; Chicago, IL. (Poster Discussion)

Mitra AP, Schuckman AK, Skinner EC, Miranda G, Daneshmand S. Evolving trends in urinary diversion following radical cystectomy: A single-institution experience over 25 years. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Presentation)

Mitra AP, Skinner EC, Schuckman AK, Miranda G, Daneshmand S. Blood loss during radical cystectomy and concomitant transfusions: Influencing factors and impact on patient outcomes. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)

Alemozaffar M, Mitra A, Fairey A, Lieskovsky G, Daneshmand S. Post-prostatectomy survival outcomes in patients with pT3 stage disease and lymph node involvement (pT3N+M0) with subsequent observation or adjuvant therapy. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Presentation)

Karnes RJ, Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJS, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, Vergara IA, Triche TJ, Black PC, Thompson RH, Jenkins RB. Validation of a genomic classifier that predicts metastatic disease progression in men with high risk pathological features post-prostatectomy. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Presentation) (AUA Take Home Messages - Prostate Cancer; Best of AUA)

Daneshmand S, Ahmadi H, Schuckman AK, Miranda G, Mitra AP, Djaladat H. Enhanced recovery after surgery in patients undergoing radical cystectomy for bladder cancer. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (Best Poster Award; AUA Take Home Messages - Bladder Cancer)

Cooperberg M, Crisan A, Mitra A, Ghadessi M, Buerki C, Davicioni E. Combined value of genomic biomarkers and CAPRA-S in predicting prostate cancer death in a high-risk surgical cohort. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (AUA Take Home Messages - Prostate Cancer)

Crisan A, Vergara I, Ghadessi M, Thompson D, Buerki C, Erho N, Siercocinski T, Haddad Z, Black P, Mitra A, Davicioni E, Jenkins R. Clinical and genomic analysis of metastatic disease progression in a background of biochemical recurrence. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)

Dolginow D, Crisan A, Buerki C, Ghadessi M, Mitra AP, Erho N, Vergara IA, Haddad Z, Sierocinski T, Triche TJ, Davicioni E. Evaluation of a genomic classifier for improved risk stratification in prostate cancer patients with specific adverse pathologies after surgery. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (AUA Take Home Messages - Prostate Cancer)

Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Feng FY, Schaeffer EM. Performance of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (Best Poster Award)

Ross A, Ghadessi M, Crisan A, Buerki C, Erho N, Vergara I, Haddad Z, Harko S, Mitra A, Thompson D, Triche T, Davicioni E, Schaeffer E. Comparison of clinical and genomic models for prediction of rapid metastatic disease after radical prostatectomy. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (AUA Take Home Messages - Prostate Cancer)

Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhaeuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Over decades, radical cystectomy with extended lymphadenectomy provides predictable outcomes to patients with muscle invasive bladder cancer - notwithstanding bladder cancer remains as deadly as 30 years ago. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)

Kluth LA, Xylinas E, Rink M, Kent M, Sjoberg D, Babjuk M, Brisuda A, Aziz A, Fritsche H, Comploj E, Pycha A, Sundi D, Bivalacqua T, Novara G, Baniel J, Mano R, Gontero P, Svatek RS, Lusuardi L, Mitra A, Daneshmand S, Galsky MD, Lotan Y, Scherr DS, Shariat SF. Prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder. AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)

Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Prognostic value of coding and non-coding genomic meta-features in rhabdomyosarcoma. AACR Annual Meeting: 2013 Apr 6-10; Washington, DC. (Poster)

Mitra AP, Haydel D, Mitra SA, Dunne J, Silveria S, Wang L, Triche TJ. Diagnosing small round cell tumors using whole transcriptome expression profiling. AACR Annual Meeting: 2013 Apr 6-10; Washington, DC. (Poster)

Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Influence of a long non-coding RNA on epigenetic, genetic and phenotypic changes in Ewing sarcoma. AACR Annual Meeting: 2013 Apr 6-10; Washington, DC. (Poster)

Kluth LA, Xylinas E, Rink M, Kent M, Sjoberg D, Babjuk M, Brisuda A, Aziz A, Fritsche H-M, Comploj E, Pycha A, Sundi D, Bivalacqua T, Novara G, Baniel J, Mano R, Gontero P, Svatek RS, Lusuardi L, Mitra A, Daneshmand S, Lotan Y, Scherr DS, Shariat SF. Validation of prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder. EAU Annual Congress: 2013 Mar 15-19; Milan, Italy. (Moderated Poster)

Jayaratna IS, Mitra AP, Dedhia R, Asbaghi S, Teruya KK, Tygenhof E, Schuckman AK. Inguinal lymph node dissection for penile carcinoma: Postoperative complications using a validated classification system. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)

Cooperberg MR, Crisan A, Mitra AP, Ghadessi M, Buerki C, Davicioni E. A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)

Badani KK, Thompson DJS, Mitra AP, Ghadessi M, Buerki C, Davicioni E, Wood PJ. Evaluation of a genomic-based prognostic test for metastasis in high-risk post-prostatectomy patients: Does it impact physician decision making? ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)

Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJS, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, Vergara IA, Triche TJ, Black PC, Thompson RH, Karnes RJ, Jenkins RB. Validation of a genomic classifier that predicts metastatic disease progression in men with high-risk pathologic features postprostatectomy. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)

Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Schaeffer EM, Feng FY. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)

Mitra A, Birkhahn M, Williams A, Barr N, Skinner E, Stein J, Skinner D, Tai YC, Datar R, Cote R. Detection and characterization of bladder cancer cells in urine using a novel membrane microfiltration device. SUO Annual Meeting: 2012 Nov 28-30; Bethesda, MD. (Poster)

Mitra A, Schuckman A, Skinner E, Miranda G, Daneshmand S. Trends in urinary diversion following radical cystectomy: Long-term experience at the University of Southern California. SUO Annual Meeting: 2012 Nov 28-30; Bethesda, MD. (Poster)

Mitra A, Ghadessi M, Bergstralh EJ, Buerki C, Erho N, Crisan A, Sierocinski T, Haddad Z, Vergara IA, Thompson DJS, Carlson R, Klee GG, Ballman KV, Kollmeyer TM, Triche TJ, Davicioni E, Black PC, Thompson RH, Karnes RJ, Jenkins RB. Development and validation of a novel genomic classifier for predicting metastatic prostate cancer in patients undergoing radical prostatectomy. SUO Annual Meeting: 2012 Nov 28-30; Bethesda, MD. (Poster)

Bartsch G, Mitra A, Mitra S, Almal A, Steven K, Fry D, Lenehan P, Worzel W, Cote R. Artificial intelligence and machine-learning algorithms with gene expression profiling: A potential approach to predicting superficial bladder cancer recurrence at initial presentation. SUO Annual Meeting: 2012 Nov 28-30; Bethesda, MD. (Poster)

Ghadessi M, Bergstralh EJ, Buerki C, Black PC, Erho NG, Crisan A, Mitra AP, Davicioni E, Feng F, Jenkins RB. Validation of a genomic-clinical classifier for predicting clinical progression in postprostatectomy high-risk prostate cancer. ASTRO Annual Meeting: 2012 Oct 28-31; Boston, MA. (Presentation)

Davicioni E, Mitra AP, Buerki C, Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Sierocinski T, Haddad Z, Vergara IA, Thompson DJS, Carlson R, Klee GG, Ballman KV, Fink S, Kollmeyer TM, Triche TJ, Black PC, Thompson RH, Karnes RJ, Jenkins RB. Development and validation of a novel genomic classifier for predicting metastatic prostate cancer in patients undergoing radical prostatectomy. Prostate Cancer Foundation Annual Scientific Retreat: 2012 Oct 25-27; Carlsbad, CA. (Poster)

Mitra AP, Birkhahn M, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. Use of a novel precision-engineered membrane microfiltration device for bladder cancer detection. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Presentation)

Mitra AP, Skinner EC, Quinn DI, Dorff TB, Miranda G, Daneshmand S. Critical analysis of gender differences on outcomes following radical cystectomy for bladder cancer. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Moderated Poster)

Mitra AP, Skinner EC, Miranda G, Daneshmand S. Blood loss during radical cystectomy: Comprehensive analysis of contributing factors and influence on patient outcome. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Moderated Poster)

Mitra AP, Schuckman A, Skinner EC, Miranda G, Daneshmand S. Evolution of urinary diversion following radical cystectomy: An institution's 25-year experience. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Moderated Poster)

Mitra AP, Daneshmand S, Dorff TB, Miranda G, Schuckman AK, Gill IS, Skinner DG, Skinner EC, Quinn DI. Impact of cigarette smoking on oncological outcomes following radical cystectomy for bladder cancer. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Poster)

Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Influence of squamous and glandular differentiation on bladder cancer outcome: A matched case-control analysis. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Poster)

Jayaratna IS, Mitra AP, Fairey AS, Schwartz RL, Dedhia RD, Asbaghi SA, Teruya K, Quinn DI, Dorff TB, Schuckman AK. Prognostic factors and survival outcomes of penile carcinoma at the University of Southern California. Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Poster)

Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen SG, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Defining a nine-biomarker panel for predicting bladder cancer outcome in combination with smoking intensity: A report from the Los Angeles Cancer Surveillance Program. ASCO Annual Meeting: 2012 Jun 1-5; Chicago, IL. (Poster) (Conquer Cancer Foundation of ASCO Merit Award)

Daneshmand S, Skinner EC, Miranda G, Mitra AP. A pre-cystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. ASCO Annual Meeting: 2012 Jun 1-5; Chicago, IL. (Poster)

Buerki C, Mitra AP, Black PC, Ghadessi M, Bergstralh EJ, Erho N, Carlson R, Crisan A, Sierocinski T, Zimmermann B, Haddad Z, Vergara IA, Ballman KV, Klee GG, Fink S, Kollmeyer TM, Triche TJ, Davicioni E, Karnes RJ, Jenkins RB. Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer. ASCO Annual Meeting: 2012 Jun 1-5; Chicago, IL. (Poster Discussion)

Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program. AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster) (Best of AUA)

Mitra AP, Birkhahn M, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. A novel precision-engineered membrane microfiltration device for capture and characterization of bladder cancer cells in urine. AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster)

Mitra AP, Bartsch G, Mitra SA, Almal AA, Steven KE, Fry DW, Lenehan PF, Cote RJ, Worzel WP. Using artificial intelligence and machine-learning algorithms with gene expression profiling to predict superficial bladder cancer recurrence at initial presentation. AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster) (Best Poster Award; Best of AUA)

Mitra AP, Masic S, Skinner EC, Cai J, Miranda G, Daneshmand S. Diagnostic and surgical delays in bladder cancer and its impact on clinical outcome. AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster) (AUA Take Home Messages - Bladder Cancer)

Mitra AP, Syan R, Skinner EC, Miranda G, Daneshmand S. Factors influencing lymph node yield during radical cystectomy with extended pelvic lymphadenectomy: Single-institution experience with a standardized dissection template. AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster)

Wopat RA, Skinner EC, Mitra AP, Cai J, Miranda G, Daneshmand S. Outcomes in patients undergoing radical cystectomy for recurrent bladder cancer following prior partial cystectomy. AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster)

Mitra AP. Securing the future of cancer research funding: The essential role of early-career scientists in advocacy. AACR Annual Meeting: 2012 Mar 31-Apr 4; Chicago, IL. (Invited Presentation)

Mitra AP, Buckley JD, Mitra SA, Davicioni E, Anderson JR, Kapranov P, Skapek SX, Hawkins DS, Triche TJ. A non-coding RNA panel is prognostically superior to standard pathologic criteria and coding transcripts in rhabdomyosarcoma. AACR Annual Meeting: 2012 Mar 31-Apr 4; Chicago, IL. (Poster)

Jayaratna IS, Schwartz RL, Mitra AP, Cai J, Ma Y, Quinn DI, Dorff TB, Schuckman A. The University of Southern California penile cancer experience: Clinicopathologic characteristics of patients from 1991-2011. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2012 Feb 2-4; San Francisco, CA. (Poster)

Schwartz RL, Jayaratna IS, Mitra AP, Da Silva D, Kast WM, Chen M, Ma Y, Quinn DI, Dorff TB, Schuckman A. HPV status in relation to clinicopathologic variables in patients with penile cancer at Los Angeles County-USC Medical Center. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2012 Feb 2-4; San Francisco, CA. (Poster)

Mitra AP, Buckley JD, Mitra SA, Davicioni E, Anderson JR, Kapranov P, Skapek SX, Hawkins DS, Triche TJ. A non-coding RNA panel predicts intermediate-risk childhood rhabdomyosarcoma prognosis better than standard pathologic criteria and coding genes. AACR Noncoding RNAs and Cancer Conference: 2012 Jan 8-11; Miami, FL. (Poster)

Mitra AP, Mitra SA, Buckley JD, Sorensen PHB, Reynolds CP, Arceci RJ, Milos P, St. Laurent G, Kapranov P, Triche TJ. Human genome contains a large number of very long intergenic transcribed regions, some of which are associated with cancer outcome. AACR Noncoding RNAs and Cancer Conference: 2012 Jan 8-11; Miami, FL. (Poster)

Jayaratna I, Schwartz R, Mitra A, Cai J, Ma Y, Quinn D, Dorff T, Schuckman A. The USC penile cancer experience: Clinicopathologic characteristics of patients from 1991-2011. SUO Annual Meeting: 2011 Nov 30-Dec 2; Bethesda, MD. (Poster)

Schwartz RL, Jayaratna I, Mitra AP, Da Silva D, Kast WM, Chen M, Ma Y, Quinn DI, Dorff TB, Schuckman AK. HPV status in relation to clinicopathological characteristics in penile cancer patients at Los Angeles County-USC (LAC-USC) Medical Center. SUO Annual Meeting: 2011 Nov 30-Dec 2; Bethesda, MD. (Poster)

Bartsch C, Mitra A, Bartsch G, Skinner E, Skinner D, Steven K, Cote R. An angiogenesis marker panel predicts the recurrence of non-invasive papillary bladder cancer at initial diagnosis. Annual Congress of the German Society of Urology: 2011 Sep 14-17; Hamburg, Germany. (Moderated Poster)

Zehnder P, Skinner EC, Studer UE, Thalmann GN, Miranda G, Cai J, Mitra AP, Skinner DG, Quinn DI, Gill IS. The outcome of patients undergoing radical cystectomy with extended lymph node dissection remains unimproved over the last 35 years. Annual Congress of the German Society of Urology: 2011 Sep 14-17; Hamburg, Germany. (Moderated Poster)

Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Identification of a biomarker panel that predicts bladder cancer outcome independent of routine prognostic factors and smoking history. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)

Mitra AP, Skinner EC, Miranda G, Daneshmand S. A decision tree approach to identifying patients with clinical T2 bladder cancer who may benefit from neoadjuvant chemotherapy. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)

Mitra AP, Bartsch CC, Bartsch G, Skinner EC, Skinner DG, Steven KE, Cote RJ. Potential of angiogenesis pathway-derived markers in predicting noninvasive bladder cancer recurrence. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Moderated Poster) (First Place, Best of Session Award; Third Place, Overall Award)

Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in bladder transitional cell carcinoma portend poor prognosis? An intensive case-control analysis. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Moderated Poster)

Mitra AP, Bartsch G, Almal AA, Steven KE, Fry DW, Lenehan PF, Cote RJ, Worzel WP. Employment of gene expression profiling and a machine-learning algorithm to predict superficial bladder cancer recurrence at initial presentation. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Moderated Poster)

Masic S, Mitra AP, Skinner EC, Cai J, Miranda G, Daneshmand S. Diagnostic and surgical delay in bladder cancer and its impact on patient outcome. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)

Syan R, Mitra AP, Skinner EC, Miranda G, Daneshmand S. Factors affecting lymph node yield during radical cystectomy. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)

Harris BN, Mitra AP, Skinner EC, Miranda G, Daneshmand S. Survival following urothelial recurrence in patients post-radical cystectomy for transitional cell carcinoma of the bladder. Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)

Mitra A, Quinn D, Dorff T, Skinner E, Schuckman A, Miranda G, Gill I, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer patients following radical cystectomy. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Presentation)

Mitra A, Skinner E, Lieskovsky G, Schuckman A, Boyd S, Miranda G, Skinner D, Daneshmand S. Radical cystectomy for transitional cell carcinoma of the bladder - The USC experience. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Presentation)

Mitra A, Tsao-Wei D, Dorff T, Groshen S, Miranda G, Schuckman A, Daneshmand S, Gill I, Skinner D, Skinner E, Quinn D. Influence of smoking history on bladder cancer patient outcome following radical cystectomy. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)

Mitra A, Castelao J, Hawes D, Tsao-Wei D, Jiang X, Shi S, Young L, Datar R, Skinner E, Stein J, Groshen S, Yu M, Ross R, Skinner D, Cortessis V, Cote R. Protein alterations predict bladder cancer outcome independent of clinicopathologic prognostic criteria and tobacco smoke exposure. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)

Bartsch C, Mitra A, Bartsch G, Skinner E, Skinner D, Steven K, Cote R. An angiogenesis-marker panel predicts noninvasive papillary bladder cancer recurrence at initial presentation. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Presentation)

Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Orthotopic urinary diversion in male patients with pT4a bladder cancer. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)

Abdelsayed GA, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. A pre-cystectomy modeling approach for predicting pathologic stage in clinically organ-confined bladder cancer. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)

Zehnder P, Daneshmand S, Leahy M, Cai J, Miranda G, Mitra A, Bartsch G, Skinner E, Gill I. Outcome analysis of patients with exclusively carcinoma in situ (CIS) following radical cystectomy and no previous history of lamina propria invasion. AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)

Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Using molecular alterations to predict bladder cancer prognosis independent of clinicopathologic parameters and cigarette smoke exposure. AACR Annual Meeting: 2011 Apr 2-6; Orlando, FL. (Poster)

Zehnder P, Daneshmand S, Leahy M, Skinner E, Cai J, Miranda G, Mitra A, Bartsch G, Gill I. Outcome in patients exclusively with carcinoma in situ (CIS) following radical cystectomy. SUO Annual Meeting: 2010 Dec 8-10; Bethesda, MD. (Poster)

Mitra AP, Hawes D, Tsao-Wei DD, Shi SR, Datar RH, Groshen S, Stein JP, Skinner EC, Skinner DG, Ross RK, Cote RJ. Combination of molecular alterations predict bladder cancer outcome independent of standard prognostic criteria and carcinogen exposure. Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Presentation)

Mitra AP, Miranda G, Dorff TB, Quinn DI, Schuckman AK, Skinner EC, Daneshmand S. Factors predictive of patient outcome following bladder cancer recurrence after radical cystectomy. Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Moderated Poster)

Mitra AP, Tsao-Wei DD, Quinn DI, Dorff TB, Miranda G, Skinner EC, Skinner DG. Impact of smoking habits on patient outcome following radical cystectomy. Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Moderated Poster)

Zehnder P, Skinner EC, Studer UE, Miranda G, Cai J, Mitra AP, Skinner DG, Quinn DI, Gill IS. Bladder cancer, an unaltered deadly disease over the last four decades. Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Presentation)

Zehnder P, Skinner EC, Studer UE, Miranda G, Cai J, Mitra AP, Skinner DG, Quinn DI, Gill IS. Meticulous extended lymph node dissection during radical cystectomy allows for recurrence risk stratification according to total nodal yield and positive nodes. Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Moderated Poster)

Mitra A, Jiang X, Castelao JE, Hawes D, Tsao-Wei DD, Shi SR, Young L, Datar RH, Skinner EC, Stein JP, Groshen S, Ross RK, Triche TJ, Skinner DG, Jones PA, Cote RJ. Molecular alterations in bladder cancer associated with carcinogen exposure and their prognostic impact: a Los Angeles County experience. AUA Annual Meeting: 2010 May 29-Jun 3; San Francisco, CA. (Moderated Poster)

Lerner SP, Stadler WM, Groshen S, Cai J, Mitra AP, Tuazon ED, Skinner DG, Raghavan D, Esrig D, Steinberg GD, Klotz L, Hall MC, Cote RJ. Cell cycle regulatory protein alterations in a prospective study of patients with organ-confined bladder cancer following radical cystectomy. AUA Annual Meeting: 2010 May 29-Jun 3; San Francisco, CA. (Moderated Poster)

Mitra AP, Jiang X, Castelao JE, Hawes D, Tsao-Wei DD, Shi SR, Young L, Datar RH, Gago-Dominguez M, Stein JP, Skinner EC, Groshen S, Ross RK, Skinner DG, Triche TJ, Jones PA, Cote RJ. Effects of smoking on the molecular pathology of urinary bladder cancer and its prognostic importance. AACR Annual Meeting: 2010 Apr 17-21; Washington, DC. (Poster)

Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. A concise 4-gene panel can predict clinical outcome in urinary bladder cancer. AUA Annual Meeting: 2009 Apr 25-30; Chicago, IL. (Presentation)

Mitra AP, Pagliarulo V, Yang D, Waldman FM, Groshen S, Cote RJ. A 4-gene panel can predict clinical outcome across all stages of urinary bladder cancer. AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster)

Mitra AP, Jiang X, Hawes D, Tsao-Wei DD, Shi SR, Castelao JE, Groshen S, Cote RJ. Associations of smoking and non-steriodal anti-inflammatory drug use with molecular alterations in urinary bladder cancer. AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster) (Outstanding Clinical Scholar Award)

Jiang X, Mitra AP, Castelao JE, Xue S, Diep AT, Haile RW, Gago-Dominguez M. p53 overexpression and colorectal cancer. AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster)

Jiang X, Mitra AP, Castelao JE, Xue S, Diep AT, Haile RW, Gago-Dominguez M. Distinguishing clinicopathologic and molecular characteristics of proximal and distal colorectal cancer. AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster)

Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. Use of a 4-gene panel to predict prognosis in urinary bladder cancer. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. (Poster)

Birkhahn M, Mitra AP, Bartsch G Jr., Ye W, Groshen S, Steven KE, Cote RJ. Use of quantitative expression profiling to identify genes that predict prognosis in Ta bladder cancer at first presentation. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. (Poster)

Youssef RF, Mitra AP, Abol-Enein H, Penson D, Mosbah A, Cai J, Groshen S, Skinner DG, Ghoneim MA, Cote RJ. Adenocarcinoma of the urinary bladder: Outcome of 322 cases from Egypt and USA. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. (Poster)

Mitra AP, Yang D, Pagliarulo V, Datar RH, Groshen SG, Cote RJ. A four-gene panel for prediction of clinical outcome in urinary bladder cancer. AACR Annual Meeting: 2008 Apr 12-16; San Diego, CA. (Poster)

Birkhahn M, Williams AW, Mitra AP, Ye W, Zhong JF, Datar RH, Groshen SG, Lam G, Steven KE, Cote RJ. Molecular markers for tumor recurrence and progression in low and high grade pTa bladder cancer. AACR Annual Meeting: 2008 Apr 12-16; San Diego, CA. (Poster)

Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. Generation of a concise prognostic gene panel for urinary bladder cancer. USC Keck School of Medicine – Annual Pathology Conference: 2008 Feb 1-2; Oxnard, CA. (Presentation)

Mitra AP, Yang D, Pagliarulo V, Groshen SG, Cote RJ. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: 2007 Oct 22-26; San Francisco, CA. (Poster) (Scholar-in-Training Award)

Mitra AP, Almal A, Pagliarulo V, George B, Yang D, Groshen S, Worzel WP, Cote RJ. Applying unsupervised and supervised techniques to analyze gene expression profiles in bladder cancer. USC Keck School of Medicine – Department of Pathology Annual Retreat: 2007 Jan 26-27; Palm Desert, CA. (Presentation)

Almal AA, Mitra AP, Datar RH, Lenehan PF, Fry DW, Cote RJ, Worzel WP. Using genetic programming to classify node positive patients in bladder cancer. Genetic and Evolutionary Computation Conference: 2006 Jul 8-12; Seattle, WA. (Presentation)

Mitra AP, Almal AA, George B, Fry DW, Lenehan PF, Pagliarulo V, Cote RJ, Datar RH, Worzel WP. Application of genetic programming in analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. USC Keck School of Medicine – Department of Pathology Annual Retreat: 2006 Jan 20-21; Oxnard, CA. (Poster)

Mitra AP. Editorial comment. J Urol 211(2):252-253, 2024. [PubMed]

Mitra AP, Mokkapati S, Navai N, Kamat AM, McConkey DJ, Dinney CPN. Utility of urine microRNAs for predicting response to intravesical bacillus Calmette-Guérin therapy. AUA News 27(11): 57-58, 2022. [Article link]

Mitra AP, Miest T, Dinney CPN. Words of wisdom: Genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer. Eur Urol 79(3):428-429, 2021. [PubMed]

Mitra AP, Dinney CPN, Miest T. Selecting the appropriate patient for timely cystectomy for non–muscle invasive bladder cancer. In: Wein A, Dmochowski R, Partin A (editors). PracticeUpdate. New York, NY: Elsevier; 2021. [PracticeUpdate]

Mitra AP, Dinney CPN, Miest T. The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis. In: Wein A, Dmochowski R, Partin A (editors). PracticeUpdate. New York, NY: Elsevier; 2020. [PracticeUpdate]

Mitra AP. Urine cytologic analysis: special techniques for bladder cancer detection. In: Kumar GL, Kiernan JA (editors). Connection (vol. 14). Carpinteria, CA: Dako; 2010. p. 169-177.

Mitra AP, Birkhahn M, Cote RJ. Reply from authors re: Joseph L. Chin. In search of the perfect crystal ball for Ta urothelial cancer. Eur Urol 2010;57:21-2. Eur Urol 57(1):23-24, 2010. [PubMed]

Mitra AP, Cote RJ. Identifying the nexus between gene and protein in assessment of p53 alterations. In: Kumar GL, Badve S (editors). Connection (vol. 13). Carpinteria, CA: Dako; 2009. p. 12-14.

Mitra AP. American Association for Cancer Research - 100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. IDrugs 12(6):339-341, 2009. [PubMed]

Mitra AP. American Association for Cancer Research – 100th Annual Meeting (Part IV), Denver, CO, USA. In: Thomson Pharma Partnering. Philadelphia, PA: Thomson Reuters Scientific. May 6, 2009.

Cote RJ, Mitra AP. Pathology and molecular biology of bladder cancer. In: Proceedings of the ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. Alexandria, VA: American Society of Clinical Oncology; 2009. p. 49-50.